This Article Full Text Full Text (PDF) All Versions of this Article: 108/20/2524    most recent 01.CIR.0000096482.02567.8Cv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Takahashi, M. Articles by Sobue, K. Search for Related Content PubMed PubMed Citation Articles by Takahashi, M. Articles by Sobue, K. Pubmed/NCBI databases Gene GEO Profiles HomoloGene OMIM UniGene Substance via MeSH Related Collections Smooth muscle proliferation and differentiation Mechanism of atherosclerosis/growth factors

(Circulation. 2003;108:2524.)
© 2003 American Heart Association, Inc.

Basic Science Reports

Epiregulin as a Major Autocrine/Paracrine Factor Released From ERK- and p38MAPK-Activated Vascular Smooth Muscle Cells

Masanori Takahashi, MD^*; Ken’ichiro Hayashi, PhD^*; Kenji Yoshida, MD^*; Yasuyuki Ohkawa, PhD; Toshi Komurasaki, PhD; Akira Kitabatake, MD, PhD; Akira Ogawa, MD, PhD; Wataru Nishida, MD, PhD; Masahiko Yano, MD, PhD; Morito Monden, MD, PhD; Kenji Sobue, MD, PhD

From the Department of Neuroscience (K.H., Y.O., W.N., K.S.) and the Department of Surgery and Clinical Oncology (M.Y., M.M.), Osaka University Graduate School of Medicine, Osaka, Japan; the Department of Cardiovascular Medicine, Hokkaido University, Graduate School of Medicine (M.T., A.K.), Sapporo, Japan; the Department of Neurosurgery, Iwate Medical University School of Medicine (K.Y., A.O.), Morioka, Japan; and the Molecular Biology Laboratory, Medical Research Laboratories, Taisho Pharmaceutical Co, Ltd (T.K.), Saitama, Japan.

Correspondence to Dr Kenji Sobue, Department of Neuroscience, Osaka University Graduate School of Medicine (D13), 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. E-mail sobue{at}nbiochem.med.osaka-u.ac.jp

Received December 31, 2002; de novo received April 23, 2003; revision received July 18, 2003; accepted July 21, 2003.

Background— The coordinated activation of extracellular signal–regulated kinase (ERK) and p38 mitogen-activated protein kinase (p38MAPK) is critical for the induction of vascular and visceral smooth muscle cell (SMC) dedifferentiation. We previously reported that on the forced activation of both MAPKs, visceral SMCs secrete a non–heparin-binding protein factor(s) that is involved in the dedifferentiation of neighboring SMCs. In this study, we sought to identify the dedifferentiation factor(s) derived from vascular SMCs (VSMCs).

Methods and Results— We fractionated the VSMC dedifferentiation factor(s) in the conditioned medium obtained from differentiated VSMCs in which both ERK and p38MAPK were forcedly activated and identified epiregulin as a major autocrine/paracrine factor for VSMC dedifferentiation. The epiregulin-induced VSMC dedifferentiation was mediated through the coordinated activation of ERK and p38MAPK. Unsaturated lysophosphatidic acid and platelet-derived growth factor-BB, which are potent VSMC dedifferentiation factors, rapidly upregulated epiregulin mRNA expression in an ERK- and p38MAPK-dependent manner. Reverse transcriptase–polymerase chain reaction and/or immunohistological analyses revealed the restricted expression of epiregulin in human atherosclerotic and balloon-injured rat arteries, in which the phenotypic modulation of medial VSMCs occurred in vivo.

Conclusions— Epiregulin is released from VSMCs primed by atherogenic factors and acts as a major autocrine/paracrine factor for VSMC dedifferentiation. It may be involved in the progression of vascular remodeling such as atherosclerosis.

Key Words: vasculature • remodeling • muscle, smooth • atherosclerosis

This article has been cited by other articles:

				E. J. Cornish, B. J. Hurtgen, K. McInnerney, N. L. Burritt, R. M. Taylor, J. N. Jarvis, S. Y. Wang, and J. B. Burritt Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase-Independent Resistance to Aspergillus fumigatus in Alveolar Macrophages J. Immunol., May 15, 2008; 180(10): 6854 - 6867. [Abstract] [Full Text] [PDF]

				S. Li, F. Takeuchi, J.-a. Wang, Q. Fan, T. Komurasaki, E. M. Billings, G. Pacheco-Rodriguez, J. Moss, and T. N. Darling Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas PNAS, March 4, 2008; 105(9): 3539 - 3544. [Abstract] [Full Text] [PDF]

				I. Airoldi, E. Di Carlo, C. Cocco, G. Taverniti, T. D'Antuono, E. Ognio, M. Watanabe, D. Ribatti, and V. Pistoia From the Cover: Endogenous IL-12 triggers an antiangiogenic program in melanoma cells PNAS, March 6, 2007; 104(10): 3996 - 4001. [Abstract] [Full Text] [PDF]

				R. D. Patel, D. J. Kim, J. M. Peters, and G. H. Perdew The Aryl Hydrocarbon Receptor Directly Regulates Expression of the Potent Mitogen Epiregulin Toxicol. Sci., January 1, 2006; 89(1): 75 - 82. [Abstract] [Full Text] [PDF]

				S. Zhuang, Y. Yan, J. Han, and R. G. Schnellmann p38 Kinase-mediated Transactivation of the Epidermal Growth Factor Receptor Is Required for Dedifferentiation of Renal Epithelial Cells after Oxidant Injury J. Biol. Chem., June 3, 2005; 280(22): 21036 - 21042. [Abstract] [Full Text] [PDF]

				K. Hayashi, K. Shibata, T. Morita, K. Iwasaki, M. Watanabe, and K. Sobue Insulin Receptor Substrate-1/SHP-2 Interaction, a Phenotype-dependent Switching Machinery of Insulin-like Growth Factor-I Signaling in Vascular Smooth Muscle Cells J. Biol. Chem., September 24, 2004; 279(39): 40807 - 40818. [Abstract] [Full Text] [PDF]

				S. Shirasawa, S. Sugiyama, I. Baba, J. Inokuchi, S. Sekine, K. Ogino, Y. Kawamura, T. Dohi, M. Fujimoto, and T. Sasazuki Dermatitis due to epiregulin deficiency and a critical role of epiregulin in immune-related responses of keratinocyte and macrophage PNAS, September 21, 2004; 101(38): 13921 - 13926. [Abstract] [Full Text] [PDF]